Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.

PubWeight™: 1.02^‹?› | Rank: Top 15%

🔗 View Article (PMC 4206465)

Published in PLoS One on October 22, 2014

Authors

Antonia Jeličić Kadić¹, Maja Žanić², Nataša Škaričić³, Ana Marušić⁴

Author Affiliations

1: Department of Anatomy, University of Split School of Medicine, Split, Croatia.
2: Department of Gynaecology and Obstetrics, University of Split Hospital Center, Split, Croatia.
3: School of Humanities and Social Sciences, University of Zagreb, Zagreb, Croatia.
4: Department of Anatomy, University of Split School of Medicine, Split, Croatia; Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.

Articles citing this ↘

Be rich or don't be sick: estimating Vietnamese patients' risk of falling into destitution. Springerplus (2015) 3.62

Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports. Eur J Clin Pharmacol (2015) 0.96

FIRST BH COCHRANE SYMPOSIUM HELD. Mater Sociomed (2016) 0.96

Essential Medicines in a High Income Country: Essential to Whom? PLoS One (2015) 0.75

Quantitative evaluation of essential medicines lists: the South African case study. BMC Health Serv Res (2016) 0.75

Articles cited by this ↗

Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ (2005) 5.65

25 years of the WHO essential medicines lists: progress and challenges. Lancet (2003) 4.95

The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol (2011) 2.38

Privatization in the health care system of Croatia: effects on general practice accessibility. Health Policy Plan (2003) 1.33

The reform of the essential medicines system in China: a comprehensive approach to universal coverage. J Glob Health (2013) 1.29

Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19

Redefining global health priorities: Improving cancer care in developing settings. J Glob Health (2014) 1.16

Applying the essential medicines concept to US preferred drug lists. Am J Public Health (2011) 1.07

New priorities for health sector reform in Central and Eastern Europe. Croat Med J (1998) 1.03

The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis. Eur J Clin Pharmacol (2012) 0.85

Drug usage by outpatients in Croatia during an 8-year period: Influence of changes in pricing policy. Int J Clin Pharmacol Ther (2012) 0.83